Labomar
ItalyWho owns Labomar?
Labomar is an Italian Pharma company, currently owned by Charterhouse Capital Partners since 2023. It changed hands in 2023, when First Capital sold.
Hand-verified · updated 2026-07-08
Open JSON · CC-BY
Key facts
- ·Held by Charterhouse Capital Partners since 2023 (3Y hold).
- ·Best return: 1.7x MOIC by First Capital (2023 exit).
Ownership history
2 ownership periods
First Capital sold Labomar to Charterhouse in 2023 after 3 years.
More from Charterhouse Capital Partners XI
Other portfolio companies in the same fund.
UK
France
SpainMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
Questions
Who owns Labomar?
Labomar is currently owned by Charterhouse Capital Partners, through Charterhouse Capital Partners XI, since 2023.
When did Charterhouse Capital Partners acquire Labomar?
Charterhouse Capital Partners acquired Labomar in 2023.
Who did Labomar sell to?
First Capital sold Labomar to Charterhouse in 2023 (Secondary), 1.7x return.
Who has owned Labomar over time?
Labomar has been through 2 private-equity ownership periods: First Capital · via First Capital · 2020–2023 · sold to Charterhouse · (Secondary) · 1.7x; Charterhouse Capital Partners · via Charterhouse Capital Partners XI · since 2023.